An aniseed-flavoured gel formulation for oral administration. Each 30 mL syringe delivers 120 mg Ivermectin and 1500 mg Praziquantel sufficient to treat a horse of 600 kg bodyweight.

Actions:

Ivermectin acts as a gamma amino-butyric acid (GABA) agonist that causes neuromuscular blockage, which causes paralysis and death of the parasite. Praziquantel kills cestodes by disrupting the integrity of the tegument and by interfering with glucose metabolism.

Indications:

For the control of adult and larval stages of the important internal parasites of horses. These include: Large strongyles, including adult and arterial larval stages of Strongylus vulgaris, adult and tissue larval stages of S. edentates, adult of S. equinus and Triodontophorus spp: Small strongyles, including benzimidazole resistant strains and adult and immature stages of Cyathostomum spp, Cylicocyclus spp, Cylicostephanus spp, Cylicodontophorus spp, and Gyalocephalus spp: Dictyocaulus arnfeldi (adult and immature), Oxyuris equi (adult and immature) Parascaris equorum (adult), Trichostrongylus axei (adult), Hebronema muscae, Strongyloides westeri, Gasterophilus spp. (oral and gastric stages) and Anoplocephala perfoliate.

Dosage and Administration:

One 5 ml syringe division of paste per 100 kg body weight, or the contents of one syringe to a 600 kg horse. These doses provide 0.2 mg Ivermectin and 2.5 mg Praziquantel per kg body weight.

One syringe division of paste per 100 kg body weight, or the contents of one syringe to a 600 kg horse.
These doses provide 0.2 mg Ivermectin and 2.5 mg Praziquantel per kg body weight.

FOR ANIMAL USE ONLY
NOT KEEP OUT OF REACH OF CHILDREN
HARMFUL IF SWALLOWED